Evidence map›Paper›PMID 35648847›Full record

ArticleScience advances2022

Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane.

Ana L Santos, Dongdong Liu, Anna K Reed, Aaron M Wyderka, Alexis van Venrooy, John T Li, Victor D Li, Mikita Misiura, Olga Samoylova, Jacob L Beckham and 6 more

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Single Atom Engineered Antibiotics Overcome Bacterial Resistance.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exploring antibiotic resistance with chemical tools.Chemical communications (Cambridge, England) · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Researchers turn to tiny robots to fight antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana L SantosDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-5450-9414
Dongdong LiuDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-7877-5477
Anna K ReedDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-9703-9109
Aaron M WyderkaDepartment of Chemistry, Rice University, Houston, TX 77005, USA.
Alexis van VenrooyDepartment of Chemistry, Rice University, Houston, TX 77005, USA.
John T LiDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-7218-8298
Victor D LiDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0003-4883-9326
Mikita MisiuraDepartment of Chemistry, Rice University, Houston, TX 77005, USA.
Olga SamoylovaDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-6026-6009
Jacob L BeckhamDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-2787-3712
Ciceron Ayala-OrozcoDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-2574-0860
Anatoly B KolomeiskyDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0001-5677-6690
Lawrence B AlemanyDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0001-7451-1020
Antonio OliverIdISBA-Fundación de Investigación Sanitaria de las Islas Baleares, Palma, Spain.
George P TegosOffice of Research, Reading Hospital, Tower Health, 420 S. Fifth Avenue, West Reading, PA 19611, USA.ORCID 0000-0002-3737-8491
James M TourDepartment of Chemistry, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-8479-9328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing occurrence of antibiotic-resistant bacteria and the dwindling antibiotic research and development pipeline have created a pressing global health crisis. Here, we report the discovery of a distinctive antibacterial therapy that uses visible (405 nanometers) light-activated synthetic molecular machines (MMs) to kill Gram-negative and Gram-positive bacteria, including methicillin-resistant

Identifiers

PMID35648847
PMCPMC9159576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.